RCPath CPD accredited
Co-presenters: Dr Ron Daniels, Birmingham & Professor Mervyn Singer, London
Chaired by: Dr Sarah Logan, London
– – – – –
If you require a certificate of attendance, details of how to obtain will appear at the end of the webinar.
Please note that once you have completed your details on the form, the certificate will be generated so please be ready to download your certificate immediately. We would like to inform delegates that each time a certificate is generated, we will be notified with details.
If you have any problems creating or downloading your certificate please contact Esme Carruthers at firstname.lastname@example.org
Ron Daniels is an NHS Consultant in Intensive Care, based in Birmingham, U.K. He’s also Executive Director of the UK Sepsis Trust and sits on the Executive Board of the Global Sepsis Alliance. In 2016 he was awarded the British Empire Medal for services to patients.
Ron’s expertise lies in translational medicine and leadership. He leads the team driving dissemination of the Sepsis 6 treatment pathway and is part of the team responsible for much of the policy and media engagement around sepsis in the U.K. and elsewhere, including the adoption of the 2017 Resolution on Sepsis by the WHO.
At home, Ron’s worked with the NHS over the last 5 years to ensure that, in England, more than 80% of patients presenting with suspected sepsis now receive appropriate antimicrobials rapidly. He’s ever mindful of the perceived conflict, and the synergies and need for collaboration, with the antimicrobial stewardship agenda.
Mervyn Singer is Professor of Intensive Care Medicine at University College London and current Chair of the International Sepsis Forum. He co-led the ‘Sepsis-3’ redefinitions task force (Singer et al. JAMA 2016) that moved the emphasis of sepsis away from the bug and more towards a dysregulated host response triggered by the infection. He has researched and published widely on sepsis, infection and antibiotic use (and abuse) in journals such as NEJM, Lancet and JAMA, covering a broad range of basic mechanistic, translational and clinical research. He also provides advice on clinical management of sepsis to various national and international bodies.
Trained in London.
Interests particularly around developing integrated and ambulatory care pathways for patients. These include the development of an ambulatory care facility for medical patients and being clinical lead for the outpatient parenteral antibiotic team in the trust. Passionate about improving communication with primary care and treating patients in the way they choose, in the right place, with the right team, at the right time.